Abstract
Background A growing body of evidence suggests that Major Depressive Disorder (MDD) may be associated with premature biological aging. However, most studies have examined brain-based and DNAm-based measures of biological age (BioAge) in isolation. Previous studies also suggest the relevance of inflammation, yet the relationship between MDD, BioAge and inflammation remains unclear.
Method We investigated two well-studied BioAge measures: BrainAge and DNA methylation age (DNAmAge) in Generation Scotland (GS:STRADL; BrainAge N=1,067; DNAmAge N=684; 26-76 years) and UK Biobank (UKB, BrainAge N=12,018, 45-80 years). Premature brain and DNAm aging was operationalised as ‘Predicted Age Difference’ (Brain-PAD and DNAm-PAD, respectively). We tested individual and additive contributions of Brain-PAD and DNAm-PAD to lifetime/current MDD using logistic regression, followed by exploratory analyses of acute inflammatory biomarkers as mediators of this relationship.
Results Lifetime MDD cases showed significantly higher BrainAge and DNAmAge, ranging from 1.60-2.45 years increase compared to controls; no differences were found for DNAmAgeHorvath or for BrainAge in UKB. Lifetime MDD associated with DNAm-PADGrimAge, DNAm-PADPhenoAge and Brain-PAD, ranging from β = .22 - .27 (UKB Brain-PAD β = .05). DNAm-PAD and Brain-PAD demonstrated shared and distinctive contributions to lifetime MDD (DNAm-PADPhenoAge plus Brain-PAD explained maximum variance, AUC=0.69, R2=9%). Six inflammation biomarkers associated with current, but not lifetime MDD; no significant mediation effects were found.
Conclusions Our findings highlight shared and distinct contributions of premature brain and DNAm aging in lifetime MDD. We found no evidence for a mediating role of inflammation, however future work utilizing more stable biomarkers may elucidate potential biological mechanisms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded in whole or in part by the Wellcome Trust (grant numbers 104036/Z/14/Z; 221890/Z/20/Z; 216767/Z/19/Z). CG was supported by The Medical Research Council and The University of Edinburgh through the Precision Medicine Doctoral Training program. LH was supported by the Veni award (09150162210201) of the Dutch Research Council (NWO). EYX is supported by the University of Edinburgh through a Doctoral College Scholarship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical permission for UK Biobank was obtained through the National Health Service (NHS) Research Ethics Service (11/NW/0382, UK Biobank project #4844) and by the NHS Tayside Research Ethics committee (05/s1401/89) for Generation Scotland.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- BrainAge
- biological age estimated from structural neuroimaging
- Brain-PAD
- predicted age difference between BrainAge and chronological age
- BioAge
- biological age
- BioAge-PAD
- predicted age difference between biological age and chronological age
- DNAmAge
- biological age estimated from DNA methylation, also known as epigenetic age
- DNAm-PAD
- predicted age difference between DNAmAge and chronological age
- GS:STRADL
- Generation Scotland: Stratifying Resilience and Depression
- Longitudinally MDD
- major depressive disorder
- PAD
- predicted age difference, i.e. difference between biological age and chronological age
- UKB
- UK Biobank
